Thermo Fisher Scientific Inc. (ETR:TN8)

Market Cap	131.26B
Revenue (ttm)	39.60B
Net Income (ttm)	6.01B
Shares Out	n/a
EPS (ttm)	15.75
PE Ratio	21.83
Forward PE	17.72
Dividend	1.49 (0.43%)
Ex-Dividend Date	Jun 13, 2025

Volume	11
Average Volume	281
Open	350.25
Previous Close	344.90
Day's Range	350.00 - 350.25
52-Week Range	336.25 - 590.90
Beta	n/a
RSI	40.89
Earnings Date	Jul 23, 2025

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, as well as diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for phar...

• Industry: Medical - Diagnostics & Research
• Sector: Healthcare
• Founded: 1956
• Employees: 125,000
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: TN8

Financial Performance

In 2024, Thermo Fisher Scientific's revenue was $42.88 billion, an increase of 0.05% compared to the previous year's $42.86 billion. Earnings were $6.34 billion, an increase of 5.67%.

Financial numbers in USD